Ovarian cancer (OC) is the sixth most common neoplasm in women. Hyperthermic intraperitoneal chemotherapy (HIPEC), a strategy combining maximal cytoreductive surgery with maximal regional chemotherapy, has been proposed to treat OC. At present, less randomized trials has determined HIPEC real impact on patients with OC. In this brief report, we reported results of selected studies of treatment with HIPEC for patients with OC. Future prospects are conclusively discussed.
Roviello, F., Roviello, G., Petrioli, R., Marrelli, D. (2015). Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 95(3), 297-305 [10.1016/j.critrevonc.2015.03.007].
Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results
ROVIELLO, FRANCO;ROVIELLO, GIANDOMENICO;MARRELLI, DANIELE
2015-01-01
Abstract
Ovarian cancer (OC) is the sixth most common neoplasm in women. Hyperthermic intraperitoneal chemotherapy (HIPEC), a strategy combining maximal cytoreductive surgery with maximal regional chemotherapy, has been proposed to treat OC. At present, less randomized trials has determined HIPEC real impact on patients with OC. In this brief report, we reported results of selected studies of treatment with HIPEC for patients with OC. Future prospects are conclusively discussed.
| File | Dimensione | Formato | |
|---|---|---|---|
|
CRIT REV ONCOL HEMATOL 2015 OVARIAN REV.pdf
non disponiibile
Descrizione: Review
Tipologia:
PDF editoriale
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
612.87 kB
Formato
Adobe PDF
|
612.87 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/983051